Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

301 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-05-16

Study Completion Date

2021-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

One of the main challenges of the health crisis caused by the COVID-19 epidemic is the availability of beds in intensive care units (ICUs) and, more importantly, the need for invasive mechanical ventilation (IVM) because the ICUs are currently reserved for intubated patients.

The experiences of both China and Italy indicate that a certain number of COVID-19 patients will require mechanical ventilation. However, the limited number of resuscitation beds and ventilators requires strict use of these scarce resources. As a significant proportion about 5% to 10%, of patients initially admitted to hospital with COVID-19 will require ventilation, it is essential to anticipate their need for resuscitation to improve the rare resource of beds and ventilator shortages in intensive care units.

The hypothesis of the study is that, in proven or suspected hospitalised and oxygen-requiring COVID-19 patients, an early predictive clinical score, calculated over the three first days of admission may allow for an earlier identification of patients who will require intubation and transfer to an intensive care unit for orotracheal intubation

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Altered Respiratory Compliance Under Invasive Mechanical Ventilation in SARS-CoV-2 & Development of Respiratory Sequels

NCT05721768

ARDS Due to Disease Caused by SARS Co-V-2 Respiratory Compliance Sequels of COVID

UNKNOWN

Intubation Prediction in COVID-19 Patients Treated With Awake Prone Positioning

NCT05060926

Acute Hypoxemic Respiratory Failure SARS-CoV-2 Virus

COMPLETED

Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.

NCT05341687

Ards Mechanical Ventilation Pressure High Extracorporeal Membrane Oxygenation

COMPLETED

Factors Associated With Failure of HFNO in COVID-19 ICU Patients

NCT05798234

COVID-19 Pneumonia

UNKNOWN

Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19

NCT04347928

COVID-19 ARDS Sars-CoV2

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Step 1: creation of the score

Cohort for the creation of clinical-biological score to predict the risk of intubation in COVID-19

Data monitoring for 48h within the first 24 hours of admission for COVID-19

Intervention Type OTHER

The admission variables and those constituting the predictive score (blood pressure, temperature, oxygenotherapy, biological analysis...) will be collected for 48 hours after enrolment (i.e within the first 24 hours of admission )

Step 2: validation of the score

Cohort for the validation of clinical-biological score to predict the risk of intubation in COVID-19

Data monitoring for 48h within the first 24 hours of admission for COVID-19

Intervention Type OTHER

The admission variables and those constituting the predictive score (blood pressure, temperature, oxygenotherapy, biological analysis...) will be collected for 48 hours after enrolment (i.e within the first 24 hours of admission )

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Data monitoring for 48h within the first 24 hours of admission for COVID-19

The admission variables and those constituting the predictive score (blood pressure, temperature, oxygenotherapy, biological analysis...) will be collected for 48 hours after enrolment (i.e within the first 24 hours of admission )

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Proven or expected COVID-19 patients hospitalised in a non-intensive care unit for less than 24 hours,
* Patients requiring oxygen therapy,
* Age ≥ 18 years old.

Exclusion Criteria

* Patients who are opposed to taking part in the study and who are opposed to the collection and use of the data that the study aims to collect.,
* Patients who can not be intubated for medical reasons,
* Pregnant women, parturient women or nursing mothers ,
* Adult person subject to a legal protection measure (guardianship, curatorship, judicial safeguard),
* Adults person who is unable to give consent and who is not subject to a legal protection measure,
* Persons deprived of their liberty by a judicial or administrative decision,
* Persons subject to psychiatric care under duress.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No